#Nutraceuticals CDMO Market Share

[industrynewsupdates]

A Comprehensive Overview of Nutraceuticals CDMO Market Landscape

The global nutraceuticals CDMO market size is expected to reach USD 67.83 billion by 2030, expanding at 7.7% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising awareness of nutraceuticals products, demand for nutraceuticals with medical benefits, and technological advancement are the some of the major factors driving the market growth.

Furthermore, increasing demand for organic and natural products is expected to drive market growth. CDMOs are responding to this demand by providing services related to sustainable manufacturing practices, natural ingredient sourcing, and certifications for organic product manufacturing. Moreover, increasing technological advancements to improve manufacturing processes and enhance product quality is anticipated to create growth opportunities for market growth. The technological advancement includes the adoption of new delivery systems, such as microencapsulation, and nano-emulsions, to improve the bioavailability and stability of nutraceutical ingredients.

Nutraceutical CDMOs are witnessing an increasing demand for customized solutions to meet the specific requirements of individual customers. Key companies are providing personalized nutrition solutions based on a person's unique health and well-being requirements. This is accomplished by lifestyle assessments, genetic testing, and personalized recommendations. Moreover, companies are exploring new delivery systems for nutraceuticals, such as nanoparticle delivery and liposome encapsulation to enhance the efficacy of the products.

On the other hand, key companies in the market undertaking various strategic initiatives such as partnerships, new service launches, mergers and acquisitions, and regional expansion to strengthen their market presence. For instance, in August 2022, Zerion Pharma entered into a partnership with Hovione to cover the use of the Dispersome platform in nutraceuticals. As part of this initiative, Hovione and ZERION will use the Dispersome technology to scale up and create commercial formulations of the antioxidant. Moreover, in October 2019, Sirio Pharma, a China-based nutraceutical contract development organization launched a plant-based nutraceutical service package. The company is actively promoting its integrated solutions for plant-based nutraceuticals through the event.

Gather more insights about the market drivers, restrains and growth of the Nutraceuticals CDMO Market

Nutraceuticals CDMO Market Report Highlights

• Based on dosage forms, the tablets & capsules segment dominated the market share of 61.43% in 2022. The growth of the segment is attributed to the formulation flexibility it offers to developers. Capsules are available in different sizes (000 to 5), offering developers with various dosing options

• On the other hand, the soft gel segment is expected to hold a significant market share in the coming years. For individuals who have trouble swallowing tablets or are averse to the idea of injections, the soft gel remains a preferred option because they are simple to take

• Based on services, manufacturing, and packaging captured a major share in 2022. Manufacturing requires substantial equipment, infrastructure, and skilled staff. By outsourcing these functions to CDMOs, nutraceutical companies can minimize capital expenses and operational expenses associated with maintaining in-house production capabilities

• Mid-sized companies held a major share of the company size segment in 2022. Mid-sized companies can provide specialized services based on the unique requirements of their customers. Mid-sized CROs can quickly adapt to changing client needs and offer individualized solutions

• North America dominated the market in 2022 due to factors such as rising awareness regarding nutraceuticals,changing lifestyles, and growing health concerns among consumers

• Some of the major players include Catalent Inc.; Lonza; NUTRASCIENCE LABS; Robinson Pharma, Inc.; Health Wright Products, Inc.; Innovations in Nutrition + Wellness; among others.

Nutraceuticals CDMO Market Segmentation

Grand View Research has segmented the global nutraceuticals CDMO market based on dosage form, services,company size, and region:

Nutraceuticals CDMO Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)

• Tablets & Capsules

• Powder

• Softgel

• Others

Nutraceuticals CDMO Services Outlook (Revenue, USD Million, 2018 - 2030)

• Product Formulation and Development

• Manufacturing and Packaging

• Research and Development (R&D)

• Regulatory Compliance

• Others

Nutraceuticals CDMO Company Size Outlook (Revenue, USD Million, 2018 - 2030)

• Small Companies

• Mid-Sized Companies

• Large Companies

Nutraceuticals CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.                

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

List of Key Players in the Nutraceuticals CDMO Market

• Catalent Inc.

• Lonza

• NUTRASCIENCE LABS

• Robinson Pharma, Inc.

• Health Wright Products, Inc.

• Innovations in Nutrition + Wellness

• INPHARMA S.p.A.

• Aenova Group

• NutraPakUSA

• SFI Health

Order a free sample PDF of the Nutraceuticals CDMO Market Intelligence Study, published by Grand View Research.

[tamanna31]

Vitamins & Dietary Supplements Procurement Intelligence: Global Market Is Expected to Exhibit CAGR of 8.5% During 2024-2030

Vitamins & Dietary Supplements - Procurement Intelligence

Vitamins & dietary supplements procurement is expected to unlock huge opportunities by harnessing advanced technologies across advanced and emerging economies. The global market size stood at USD 178.5 billion in 2023. Traction for health and wellness is evolving among America consumers as they seek supplements tailored to their needs. Notably, North America dominated the industry in 2023, accounting for 35% of the overall market share, followed by Europe and Asia Pacific.

Meanwhile, Europe is anticipated to witness growth owing to increased consumer awareness of health and the role of supplements in weight control and physical activity as well as their readiness to pursue a healthier lifestyle. The Asia Pacific region is poised to observe the fastest growth rate during the forecasted period. This growth is attributed to increasing consumer awareness & purchasing power along with a rise in the geriatric population in countries such as Japan and China.

Vitamins & dietary supplements are manufactured in several forms, such as tablets, capsules, powders, liquids, and gels. By type, the products are segmented into vitamin subtypes (e.g., A, B, C, D, E, and K), minerals, amino acids, enzymes, and probiotics. The products have end-use applications in pharmaceuticals, nutraceuticals, feed products, foods and beverages, and personal care products. A few of the key raw materials used in manufacturing these products include retinol, carotenoids, thiamin, riboflavin, ascorbic acid, cholecalciferol, calcium carbonate, and magnesium aspartate.

Key technologies driving the growth include nanoencapsulation, biohacking and targeted supplementation, nutrigenomics, 3D printing of capsules, and lab-grown nutrients. For instance, nanoencapsulation provides various benefits, such as improving the stability and solubility of bioactive compounds used in the manufacturing of vitamins and dietary supplements. It also inhibits the deterioration of products during storage and transportation. It also enhances the bioavailability and potency of the target compounds in the products.

Industry players purchase raw materials and active ingredients from a variety of sources and locations. The profit margins are typically moderate to low due to intense competition. The key players usually compete over pricing strategies, product innovations, packaging, labeling, and advertising. Customers can be selective, as their objective is to purchase the best available options at the lowest feasible cost. This increases the pressure on key players to provide competitive pricing and high-quality products. Besides, regulatory guidelines in several countries require companies to have stringent quality control and safety standards.

Vitamins & dietary supplements may either be manufactured in-house or through contract development & manufacturing organizations (CDMOs). They may be distributed via offline or online distribution channels. Offline channels include brick-and-mortar establishments such as direct sellers, pharmacies, hypermarkets, supermarkets, convenience stores, or other tangible shop environments. Online channels comprise e-pharmacies (Walgreens, CVS, PharmEasy) and e-commerce platforms (Amazon, eBay, Flipkart).

The COVID-19 pandemic caused significant disruption in the global vitamins and dietary supplements industry. The product demand intensified after the COVID-19 outbreak, due to the surge in demand for immunity-boosting products. Supply disruptions were prevalent due to transportation bottlenecks and labor shortages during government-imposed lockdowns, but the supply stabilized significantly in 2023 to meet the increased global demand.

Order your copy of the Vitamins & Dietary Supplements Procurement Intelligence report 2024-2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

Vitamins & Dietary Supplements Sourcing Intelligence Highlights

The vitamins & dietary supplements market has a fragmented landscape, with intense competition among the service providers.

Countries such as India and China are the preferred low-cost/ best-cost countries for vitamins and dietary supplements owing to cheap raw material costs, cheap labor costs, competitive pricing, and high return on investment.

Buyers have high negotiating power due to the intense competition among the service providers based on the scope of services and prices, enabling the buyers with flexibility to switch to a better alternative.

Raw materials, labor, technology and equipment, energy and utilities, packaging, labeling, and logistics, and other costs are the major cost components of the vitamins & dietary supplements. Other costs include R&D, regulatory and compliance, rent, general and administrative, sales and marketing, and finance and taxes.

List of Key Suppliers

Abbott Laboratories

Amway Corporation

Archer Daniels Midland Company (ADM)

BASF SE

Bayer AG

DSM Nutritional Products AG

GlaxoSmithKline plc (GSK)

Herbalife International, Inc.

Lonza Group Limited

Pfizer, Inc.

American Health Inc.

RBK Nutraceuticals Pty Ltd.

Browse through Grand View Research’s collection of procurement intelligence studies:

Advertising Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Corn Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Digital Procurement Systems Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Vitamins & Dietary Supplements Procurement Intelligence Report Scope

Vitamins & Dietary Supplements Category Growth Rate: CAGR of 8.5% from 2024 to 2030

Pricing Growth Outlook: 5% - 10% increase (Annually)

Pricing Models: Cost-plus pricing, competition-based pricing, demand-based pricing, bundled pricing

Supplier Selection Scope: Cost and pricing, past engagements, productivity, geographical presence

Supplier Selection Criteria: Geographical service provision, revenue generated, key regulatory certifications, years in service, employee strength, clientele, product portfolio, key technologies, distribution channels, application/end-use, customer ratings, and others.

Report Coverage: Revenue forecast, supplier ranking, supplier matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model